Verona Pharma PLC American Depositary Share (VRNA) Competitors $105.33 -0.47 (-0.44%) As of 02:58 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock VRNA vs. ONC, BNTX, INSM, TEVA, SMMT, GMAB, VTRS, RDY, ASND, and MRNAShould you be buying Verona Pharma PLC American Depositary Share stock or one of its competitors? The main competitors of Verona Pharma PLC American Depositary Share include BeOne Medicines (ONC), BioNTech (BNTX), Insmed (INSM), Teva Pharmaceutical Industries (TEVA), Summit Therapeutics (SMMT), Genmab A/S (GMAB), Viatris (VTRS), Dr. Reddy's Laboratories (RDY), Ascendis Pharma A/S (ASND), and Moderna (MRNA). These companies are all part of the "pharmaceutical products" industry. Verona Pharma PLC American Depositary Share vs. Its Competitors BeOne Medicines BioNTech Insmed Teva Pharmaceutical Industries Summit Therapeutics Genmab A/S Viatris Dr. Reddy's Laboratories Ascendis Pharma A/S Moderna BeOne Medicines (NASDAQ:ONC) and Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, media sentiment, earnings, analyst recommendations, institutional ownership, risk, profitability and dividends. Which has higher earnings and valuation, ONC or VRNA? Verona Pharma PLC American Depositary Share has lower revenue, but higher earnings than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Verona Pharma PLC American Depositary Share, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBeOne Medicines$3.81B9.01-$644.79M-$1.73-181.13Verona Pharma PLC American Depositary Share$42.28M212.08-$173.42M-$0.99-106.39 Do analysts prefer ONC or VRNA? BeOne Medicines presently has a consensus target price of $330.89, indicating a potential upside of 5.59%. Verona Pharma PLC American Depositary Share has a consensus target price of $109.00, indicating a potential upside of 3.48%. Given BeOne Medicines' stronger consensus rating and higher possible upside, equities analysts plainly believe BeOne Medicines is more favorable than Verona Pharma PLC American Depositary Share.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BeOne Medicines 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00Verona Pharma PLC American Depositary Share 0 Sell rating(s) 12 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14 Which has more volatility and risk, ONC or VRNA? BeOne Medicines has a beta of 0.27, meaning that its share price is 73% less volatile than the S&P 500. Comparatively, Verona Pharma PLC American Depositary Share has a beta of 0.12, meaning that its share price is 88% less volatile than the S&P 500. Do insiders & institutionals have more ownership in ONC or VRNA? 48.6% of BeOne Medicines shares are owned by institutional investors. Comparatively, 85.9% of Verona Pharma PLC American Depositary Share shares are owned by institutional investors. 6.6% of BeOne Medicines shares are owned by insiders. Comparatively, 4.8% of Verona Pharma PLC American Depositary Share shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth. Is ONC or VRNA more profitable? BeOne Medicines has a net margin of -3.89% compared to Verona Pharma PLC American Depositary Share's net margin of -36.62%. BeOne Medicines' return on equity of -1.22% beat Verona Pharma PLC American Depositary Share's return on equity.Company Net Margins Return on Equity Return on Assets BeOne Medicines-3.89% -1.22% -0.72% Verona Pharma PLC American Depositary Share -36.62%-21.12%-9.07% Does the media prefer ONC or VRNA? In the previous week, BeOne Medicines had 4 more articles in the media than Verona Pharma PLC American Depositary Share. MarketBeat recorded 11 mentions for BeOne Medicines and 7 mentions for Verona Pharma PLC American Depositary Share. Verona Pharma PLC American Depositary Share's average media sentiment score of 1.65 beat BeOne Medicines' score of 0.32 indicating that Verona Pharma PLC American Depositary Share is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BeOne Medicines 6 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Verona Pharma PLC American Depositary Share 7 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryBeOne Medicines beats Verona Pharma PLC American Depositary Share on 10 of the 16 factors compared between the two stocks. Get Verona Pharma PLC American Depositary Share News Delivered to You Automatically Sign up to receive the latest news and ratings for VRNA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRNA vs. The Competition Export to ExcelMetricVerona Pharma PLC American Depositary ShareMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$8.97B$3.12B$5.76B$9.55BDividend YieldN/A2.23%4.53%4.07%P/E Ratio-106.4720.4630.4325.11Price / Sales212.08237.31392.2187.48Price / CashN/A42.3737.0358.50Price / Book32.217.959.016.20Net Income-$173.42M-$54.72M$3.26B$265.38M7 Day Performance0.06%1.56%1.00%-1.25%1 Month Performance0.41%5.71%4.19%-0.81%1 Year Performance276.31%9.01%28.39%18.83% Verona Pharma PLC American Depositary Share Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRNAVerona Pharma PLC American Depositary Share2.4183 of 5 stars$105.33-0.4%$109.00+3.5%+285.1%$8.97B$42.28M-106.4730Positive NewsShort Interest ↓ONCBeOne Medicines0.687 of 5 stars$319.32-0.6%$330.89+3.6%N/A$35.00B$3.81B-184.5811,000BNTXBioNTech1.6389 of 5 stars$112.55-0.9%$135.80+20.7%+25.7%$27.06B$2.98B-70.346,772Analyst RevisionINSMInsmed4.1155 of 5 stars$127.27-0.4%$129.57+1.8%+69.9%$26.90B$363.71M-22.291,271Trending NewsAnalyst ForecastInsider TradeTEVATeva Pharmaceutical Industries3.5644 of 5 stars$18.08+1.2%$24.71+36.7%-3.7%$20.74B$16.54B-113.0036,830Positive NewsSMMTSummit Therapeutics2.3809 of 5 stars$26.29-1.5%$35.00+33.1%+110.2%$19.53BN/A-26.03110News CoverageAnalyst ForecastGMABGenmab A/S3.8755 of 5 stars$23.42+0.5%$37.60+60.5%-11.5%$15.02B$3.12B11.772,682Positive NewsAnalyst DowngradeAnalyst RevisionVTRSViatris2.0063 of 5 stars$10.63+0.2%$10.40-2.2%-8.7%$12.39B$14.74B-3.6732,000RDYDr. Reddy's Laboratories3.043 of 5 stars$14.26+0.2%$16.95+18.9%-15.0%$11.90B$3.81B21.6027,811News CoverageGap UpASNDAscendis Pharma A/S2.5085 of 5 stars$194.08-2.1%$242.93+25.2%+39.3%$11.88B$393.54M-37.611,017News CoveragePositive NewsAnalyst ForecastMRNAModerna4.3827 of 5 stars$28.09+0.2%$43.59+55.2%-69.1%$10.93B$3.24B-3.735,800 Related Companies and Tools Related Companies ONC Alternatives BNTX Alternatives INSM Alternatives TEVA Alternatives SMMT Alternatives GMAB Alternatives VTRS Alternatives RDY Alternatives ASND Alternatives MRNA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRNA) was last updated on 8/21/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Verona Pharma PLC American Depositary Share Please log in to your account or sign up in order to add this asset to your watchlist. Share Verona Pharma PLC American Depositary Share With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access